A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.

Kamath, S; Blann, A D; Chin, B S P; Lanza, F; Aleil, B; Cazenave, J P; Lip, G Y H

Kamath, S; Blann, A D; Chin, B S P; Lanza, F; Aleil, B; Cazenave, J P; Lip, G Y H.

Affiliation

Kamath S; Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.

Eur Heart J ; 23(22): 1788-95, 2002 Nov.

Article in En | MEDLINE | ID: mdl-12419299

Subject(s)

Anticoagulants/therapeutic use; Aspirin/therapeutic use; Atrial Fibrillation/drug therapy; Platelet Activation/drug effects; Platelet Aggregation Inhibitors/therapeutic use; Warfarin/therapeutic use; Aged; Atrial Fibrillation/physiopathology; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay/methods; Female; Fibrin Fibrinogen Degradation Products/analysis; Glycoproteins/analysis; Humans; Male; Multivariate Analysis; beta-Thromboglobulin/analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Warfarin / Platelet Aggregation Inhibitors / Platelet Activation / Aspirin / Anticoagulants Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Eur Heart J Year: 2002 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links